Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren and valsartan in post-acute coronary syndrome
NCT00409578Phase 2Completed
- Sponsor
- Novartis
- Start
- Feb 2007
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of aliskiren, valsartan in acute coronary syndrome (ACS), sponsored by Novartis. Started Feb 2007; status: completed.
02
Drugs
aliskirenvalsartan
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00409578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00409578.